HRP20241128T1 - Postupak sinteze eliglustata i njegovih intermedijarnih spojeva - Google Patents

Postupak sinteze eliglustata i njegovih intermedijarnih spojeva Download PDF

Info

Publication number
HRP20241128T1
HRP20241128T1 HRP20241128TT HRP20241128T HRP20241128T1 HR P20241128 T1 HRP20241128 T1 HR P20241128T1 HR P20241128T T HRP20241128T T HR P20241128TT HR P20241128 T HRP20241128 T HR P20241128T HR P20241128 T1 HRP20241128 T1 HR P20241128T1
Authority
HR
Croatia
Prior art keywords
compound
image
hydroxy
protecting group
hydrogen
Prior art date
Application number
HRP20241128TT
Other languages
English (en)
Croatian (hr)
Inventor
Yu Liu
Guanneng Yu
Zhiguo Zheng
Original Assignee
Zhejiang Ausun Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Ausun Pharmaceutical Co., Ltd. filed Critical Zhejiang Ausun Pharmaceutical Co., Ltd.
Publication of HRP20241128T1 publication Critical patent/HRP20241128T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/24Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
    • C07C209/26Preparation of compounds containing amino groups bound to a carbon skeleton by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds by reduction with hydrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
HRP20241128TT 2017-03-21 2017-10-16 Postupak sinteze eliglustata i njegovih intermedijarnih spojeva HRP20241128T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710169305.9A CN106967042B (zh) 2017-03-21 2017-03-21 依利格鲁司他的合成方法及其中间体化合物
PCT/CN2017/106348 WO2018171173A1 (zh) 2017-03-21 2017-10-16 依利格鲁司他的合成方法及其中间体化合物
EP17901540.9A EP3611171B1 (en) 2017-03-21 2017-10-16 Method for synthesis of eliglustat and intermediate compounds thereof

Publications (1)

Publication Number Publication Date
HRP20241128T1 true HRP20241128T1 (hr) 2024-11-22

Family

ID=59329206

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20241128TT HRP20241128T1 (hr) 2017-03-21 2017-10-16 Postupak sinteze eliglustata i njegovih intermedijarnih spojeva

Country Status (10)

Country Link
US (2) US9988364B1 (https=)
EP (2) EP4417605A3 (https=)
JP (2) JP7098651B2 (https=)
KR (1) KR102547559B1 (https=)
CN (2) CN106967042B (https=)
ES (1) ES2986115T3 (https=)
HR (1) HRP20241128T1 (https=)
HU (1) HUE068098T2 (https=)
PT (1) PT3611171T (https=)
WO (1) WO2018171173A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106967042B (zh) 2017-03-21 2020-08-14 浙江奥翔药业股份有限公司 依利格鲁司他的合成方法及其中间体化合物
US20200306225A1 (en) * 2017-10-27 2020-10-01 Msn Laboratories Private Limited, R&D Center Stable n-((1r,2r)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl) octanamide (2r,3r)-2,3-dihydroxysuccinate premix and process for preparation thereof
WO2020020365A1 (zh) * 2018-07-27 2020-01-30 中国医学科学院药物研究所 制备光活依格鲁特的方法
CN110759885B (zh) * 2018-07-27 2021-10-22 中国医学科学院药物研究所 制备光活依格鲁特的方法
CN110878079A (zh) * 2018-12-31 2020-03-13 北京启慧生物医药有限公司 一种高纯度依利格鲁司他的制备方法
CN110256321B (zh) * 2019-06-12 2021-05-28 山东省医学科学院药物研究所(山东省抗衰老研究中心、山东省新技术制药研究所) (2r,3s,4s)-4-氨基-2-十四烷基吡咯烷-3-醇的制备方法及其应用
CN113893346B (zh) * 2020-06-22 2022-11-18 四川大学华西医院 Gcs抑制剂在制备治疗可卡因成瘾的药物中的用途
CN112125805B (zh) * 2020-09-11 2022-10-18 北京红惠新医药科技有限公司 水溶性厚朴酚衍生物及和厚朴酚衍生物和其中间体的制备方法、和相关的单羟基保护中间体
CN113880819B (zh) * 2021-09-18 2024-09-20 浙江大学医学院附属第一医院 立他司特的制备方法及其中间体化合物
CN114456089B (zh) * 2022-03-29 2023-05-23 南昌航空大学 一种路易斯酸促进的烯烃和肟酯与胺的三组分反应方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2453978C (en) * 2001-07-16 2011-10-11 Genzyme Corporation Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
CN104557851B (zh) * 2015-02-10 2017-04-05 苏州明锐医药科技有限公司 依鲁司他的制备方法
WO2017068496A1 (en) 2015-10-20 2017-04-27 Dr. Reddy' S Laboratories Limited Improved process for the preparation of eliglustat and its salts
CN105646442A (zh) * 2015-10-27 2016-06-08 北京凯莱天成医药科技有限公司 一种依利格鲁司他的制备方法
CN106349210A (zh) 2016-08-24 2017-01-25 北京阳光诺和药物研究有限公司 一种制备酒石酸艾力骨司坦的方法
CN106349310B (zh) 2016-08-26 2019-06-11 内蒙古嘉宝仕生物科技股份有限公司 甲氨基阿维菌素苯甲酸盐的制备方法
CN106967042B (zh) * 2017-03-21 2020-08-14 浙江奥翔药业股份有限公司 依利格鲁司他的合成方法及其中间体化合物

Also Published As

Publication number Publication date
ES2986115T3 (es) 2024-11-08
JP2022058564A (ja) 2022-04-12
CN106967042A (zh) 2017-07-21
EP3611171A1 (en) 2020-02-19
US11697644B2 (en) 2023-07-11
KR102547559B1 (ko) 2023-06-26
JP7307823B2 (ja) 2023-07-12
EP4417605A3 (en) 2025-03-12
CN106967042B (zh) 2020-08-14
WO2018171173A1 (zh) 2018-09-27
JP7098651B2 (ja) 2022-07-11
US20200031808A1 (en) 2020-01-30
CN110461826A (zh) 2019-11-15
PT3611171T (pt) 2024-09-04
EP3611171B1 (en) 2024-06-12
KR20190140927A (ko) 2019-12-20
US9988364B1 (en) 2018-06-05
HUE068098T2 (hu) 2024-12-28
CN110461826B (zh) 2023-08-25
JP2020511508A (ja) 2020-04-16
EP4417605A2 (en) 2024-08-21
EP3611171A4 (en) 2021-03-03

Similar Documents

Publication Publication Date Title
HRP20241128T1 (hr) Postupak sinteze eliglustata i njegovih intermedijarnih spojeva
Navarro et al. Synthesis of novel (NHC) Pd (acac) Cl complexes (acac= acetylacetonate) and their activity in cross-coupling reactions
CN104262344B (zh) 艾德拉尼的制备方法
RU2012146086A (ru) Способ получения производных сульфонамидобензофурана
Sawada et al. Preparation of new chiral bisoxazoline ligands for the catalytic asymmetric intramolecular cyclopropanation of α-diazo-β-keto phenyl sulfone to afford a useful bicyclo [3.1. 0] hexane derivative
UA101482C2 (ru) Способ получения 2'-дезокси-5-азацитидина (децитабина)
RS64545B1 (sr) Postupak za pripremu n-(5-(4-(4-formil-3-fenil-1h-pirazol-1-il)pirimidin-2-ilamino)-4-metoksi-2-morfolinofenil)akrilamida
Arupula et al. Chemoselective cyclization of N-sulfonyl ketimines with ethenesulfonyl fluorides: access to trans-cyclopropanes and fused-dihydropyrroles
HRP20030566B1 (en) Improved process for carbapenem synthesis
JP5968537B2 (ja) エゼチミブの合成方法およびその方法で使用される中間体
A. Clarke et al. The development of pot, atom and step economic (PASE) synthesis of functionalised tetrahydropyrans, dihydropyrans and piperidines
RU2009100922A (ru) Новые фосфиновые кислоты и их серосодержащие производные, и способы их получения
AU2003290629B8 (en) Method for the catalytic production of hydrocodone and hydromorphone
Wei et al. Iron-catalyzed three-component tandem process: a novel and convenient synthetic route to quinoline-2, 4-dicarboxylates from arylamines, glyoxylic esters, and α-ketoesters
Zhang et al. Highly efficient synthesis of polysubstituted 1, 2-dihydroquinolines via cascade reaction of α-ketoesters with arylamines mediated by iodine
CZ300544B6 (cs) Deriváty chromanu, zpusob jejich prípravy a použití jako meziproduktu pro syntézu léciv
Bandgar et al. Regioselective ring opening of epoxides with thiols under solvent free and mild conditions using heterogeneous catalyst
JP2018505179A5 (https=)
FR2973377B1 (fr) Derives de la 2,9-dipyridyl-1,10-phenanthroline utiles comme ligands des actinides, leur procede de synthese et leurs utilisations
Cao et al. Metal-free catalytic synthesis of diaryl thioethers under mild conditions
EP2128167A1 (en) Phosphoroamide compound, method for producing the same, ligand, complex, catalyst, and method for producing optically active alcohol
Park et al. Enantioselective Hydrosilylation of Imines Catalyzed by Diamine-Zinc Complexes
Doyle et al. Enantioselectivity for catalytic cyclopropanation with diazomalonates
EP1614672A1 (en) An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
Barluenga et al. Rhodium (I)-catalyzed [3+ 2+ 2]-cyclization of alkenyl Fischer carbene complexes with methyl buta-2, 3-dienoate